We are live on ! Find out more
CABA icon

Cabaletta Bio

97 hedge funds and large institutions have $623M invested in Cabaletta Bio in 2023 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 47 increasing their positions, 10 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

370% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 10

117% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 12

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

94% more call options, than puts

Call options by funds: $1.44M | Put options by funds: $741K

32% more capital invested

Capital invested by funds: $470M → $623M (+$152M)

15% more funds holding

Funds holding: 8497 (+13)

10.93% more ownership

Funds ownership: 91.81%102.75% (+11%)

Holders
97
Holders Change
+13
Holders Change %
+15.48%
% of All Funds
1.54%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
26
Increased
47
Reduced
10
Closed
12
Calls
$1.44M
Puts
$741K
Net Calls
+$696K
Net Calls Change
-$208K
Name Holding Trade Value Shares
Change
Change in
Stake
AAA
101
Affinity Asset Advisors
New York
-$1.61M -125,000 Closed
Marshall Wace
102
Marshall Wace
United Kingdom
-$1.11M -85,696 Closed
Renaissance Technologies
103
Renaissance Technologies
New York
-$1M -77,700 Closed
GCP
104
GSA Capital Partners
United Kingdom
-$502K -38,919 Closed
V
105
Veritable
Delaware
-$481K -37,245 Closed
American Century Companies
106
American Century Companies
Missouri
-$179K -13,873 Closed
FDCC
107
Foster Dykema Cabot & Co
Massachusetts
-$4K -309 Closed
IPW
108
Impact Partnership Wealth
Georgia
-$3.52K -273 Closed
NC
109
NewSquare Capital
Pennsylvania
-$129 -10 Closed

CABA Hedge Fund Activity: Q3 2023 in Review

97 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Cabaletta Bio (CABA) for Q3 2023, worth a combined $623M — up 32% from $470M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new CABA positions and 12 closed out — a net gain of 14 holders — while 47 added to existing stakes and 10 trimmed.

The largest buyer was Holocene Advisors, opening a new position worth an estimated $16.2M. The largest seller was Boxer Capital, exiting entirely with an estimated $6.97M sold.

  • 97 institutional investors held Cabaletta Bio (CABA) as of Q3 2023, up from 84 in Q2 2023.
  • Funds reported $623M of Cabaletta Bio stock for Q3 2023, up 32% quarter-over-quarter.
  • 26 funds opened new Cabaletta Bio positions in Q3 2023 and 12 closed out, a net change of +14 holders.
  • The largest Cabaletta Bio buyer in Q3 2023 was Holocene Advisors, an estimated $16.2M added.
  • The largest Cabaletta Bio seller in Q3 2023 was Boxer Capital, an estimated $6.97M sold.

Based on aggregated 13F filings for Q3 2023.